Emerging Determinants and Outcomes in Liver Disease: From Population Trends to Patient-Centered Insights

Nov 10 2025
Convention Center: Room 145, Level 1
8:00 AM - 9:30 AM

World Class Speakers

Nneka Ufere, MD MSCE
Abstract Presenter

Nneka Ufere, MD MSCE

Massachusetts General Hospital
Cristal Brown, MD
Abstract Presenter

Cristal Brown, MD

University of Texas at Austin Dell Medical School
Therese Bittermann, MD
Abstract Presenter

Therese Bittermann, MD

Royal Brisbane and Women's Hospital, Metro North Health
Cristal Brown, MD
Moderator

Cristal Brown, MD

University of Texas at Austin Dell Medical School
Therese Bittermann, MD
Moderator

Therese Bittermann, MD

Royal Brisbane and Women's Hospital, Metro North Health

Description

Abstract Parallel sessions feature oral presentations from the authors of highly-rated abstracts submitted for presentation at The Liver Meeting.

Journey Maps

Presentations

8:45 AM - 9:00 AM
May 18 2026
Washington, D.C.

Patient-reported symptom burden as a predictor of hospitalizations in a multisite cohort of patients with advanced liver disease: Results from the PACE-LT Consortium

Nneka Ufere, MD MSCE , Abstract Presenter
ALD
Liver Cancer
Public Health
8:15 AM - 8:30 AM
May 18 2026
Washington, D.C.

Temporal and Demographic Trends in Liver Disease and Liver Cancer Mortality Attributable to Substance Use Disorders in the United States, 1999–2020

Cristal Brown, MD , Abstract Presenter
ALD
Liver Cancer
Public Health
8:30 AM - 8:45 AM
May 18 2026
Washington, D.C.

Associations of Primary Biliary Cholangitis and Primary Sclerosis Cholangitis with Adverse Pregnancy Outcomes: A Propensity-Score Matched Analysis of a National Cohort

Therese Bittermann, MD , Abstract Presenter
ALD
Liver Cancer
Public Health

Objectives

  • Explore novel epidemiological insights into liver disease and liver cancer, including the impact of lifestyle factors, substance use, and social determinants on liver-related mortality.
  • Examine clinical associations between liver conditions (e.g., PBC, PSC, cirrhosis) and broader health outcomes such as pregnancy complications and hospitalization risks.
  • Discuss real-world data applications in understanding inpatient management and symptom burden in advanced liver disease, highlighting opportunities for improving care delivery and patient outcomes.